Drugs / Glycerol
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05497934 | Oct 2022 → Oct 2023 | tympanosclerosis | Nova Scotia Health Authority | Withdrawn | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02624661 | May 2016 → Jan 2019 | headache disorder, trigeminal neuralgia | Norwegian University of Science and Technology | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00779792 | Sep → Nov 2008 | occupational dermatitis | Odense University Hospital | Unknown | No outcome recorded |
| Phase not applicable5 trials · 1 missed | ||||||
| — | NCT06955130 | Jul 2026 → Apr 2029 expected | obesity disorder, type 2 diabetes mellitus | Rutgers, The State University of New Jersey | Not yet recruiting | No outcome recorded |
| — | NCT02517307 | Feb 2016 → Jan 2021 | carnitine palmitoyl transferase II deficiency, myopathic form, long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, medium chain acyl-CoA dehydrogenase deficiency, mitochondrial trifunctional protein deficiency +1 | Oregon Health and Science University | Completed | Missed primary |
| — | NCT00184899 | Aug 2005 → Aug 2006 | metabolic syndrome X, obesity disorder | Radboud University Medical Center | Completed | No outcome recorded |
| — | NCT00333671 | Dec 2004 → Feb 2006 | diabetic macular edema | Glostrup University Hospital, Copenhagen | Completed | No outcome recorded |
| — | NCT00005889 | Oct 1999 → ? | hyperglycemia | National Center for Research Resources (NCRR) | Unknown | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 3 | NCT04087421 Comparator | Sep 2019 → Dec 2026 expected | rectal cancer | University of Aarhus | Recruiting | No outcome recorded |
| Phase 3 | NCT00619203 Comparator | Mar 2008 → Mar 2012 | bacterial meningitis | Kamuzu University of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT01054989 Comparator | Mar 2009 → Sep 2011 | — | German Diabetes Center | Completed | No outcome recorded |
| — | NCT00786487 Comparator | Jan 2009 → Jan 2014 | — | University of Minnesota | Completed | Missed primary |
| — | NCT00152945 Background | Apr 2005 → Jul 2008 | — | University Health Network, Toronto | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glycerol | “Glycerol infusion over 6 hours” NCT01054989 ↗ |
| Known as | d5-glycerol | “the form of glycerol is d5-glycerol” NCT00152945 ↗ |
| Modality | Small molecule | “Leucine, an amino acid and glycerol, an intermediary metabolite” NCT00152945 ↗ |
| Route | Intravenous | “[2-13C]glycerol IV over 10 hours” NCT00005889 ↗ |